//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
Euromit 2026, the international congress dedicated to mitochondrial diseases research will take place in #Angers, France from May 30 to June 4, 2026 : cutting-edge science, clinical updates and networking. Visit website : https://www.euromit2026.eu/
Euromit-2026
Partner #Euromit2026 to #Angers, the #FondationVISIO is invested in scientific research projects, technological innovation, cultural, educational and sporting accessibility for visually impaired children and adults. A commitment that resonates with the spirit of the Euromit congress.
As a clinical-stage biotech company, OMEICOS is developing first-in-class small-molecule therapies targeting mitochondrial dysfunction and inflammation, inter alia to resolve unmet clinical needs in primary mitochondrial disease PMD.
Proud to welcome Fondation VISIO at the #Euromit2026 Congress. Spotlight on their call for early-career researchers in ophthalmology: innovative clinical projects, developed with French institutions, to advance care and improve outcomes in visual impairment. 🔬🤝
From thymidine kinase 2 deficiency (TK2d) recognition to management Diagnosis pathways are rarely linear and shaped by key clinical decisions. At #Euromit2026, UCB joins scientific exchange on TK2d, through sessions, exhibition, and a symposium on the journey from recognition to disease management.💬
Stealth BioTherapeutics is proud to support #Euromit2026 as a Gold Sponsr Come meet us at exhibition booth #3 to learn about our latest research. #euromit2026 #MitochondiralMedicine
👋 Join us at EUROMIT to learn more about our Phase 2a PMD-OPTION clinical trial results - PMD-OPTION omeicos.com/omeicos-ther...
Connecting the thymidine kinase 2 deficiency (TK2d) community at #Euromit2026 The congress brings together experts in mitochondrial disease research. As a Diamond sponsor, UCB will contribute to scientific exchange through sessions, a symposium and exhibition presence. 🤝 #TK2d #MitochondrialDisease
#OMEICOS is pleased to participate in #EUROMIT-2026 this May as Silver Sponsor. We firmly believe shared insights drive innovation 🚀 and we are excited to connecting with the community. www.omeicos.com #MitochondrialDisease #MitochondrialHealth #Mitochondria #PMD
Stealth BioTherapeutics is proud to support #Euromit2026 as a Gold Sponsor. Come meet us at exhibition booth #3 to learn about our latest research. #euromit2026 #MitochondrialMedicine
We had a wonderful few days at #Euromit2026 with many of the leading mitochondrial medicine researchers and clinicians around the world. Thanks for sharing your important work and learning about ours! #PRIZM #MELAS #MitochondrialDisease #Biosky @euromit-2026.bsky.social
13d
29d
1mo
1mo
24d
29d
24d
29d
Video
1mo
6d
Euromit-2026
Euromit-2026
Euromit-2026
Euromit-2026
Euromit-2026
Euromit-2026
Euromit-2026
Euromit-2026
Euromit-2026
Tisento Therapeutics
Video